Association between PM2.5 and risk of hospitalization for myocardial infarction: a systematic review and a

Zeynab Farhadi1, Hasan Abulghasem Gorgi2,3, Hosein Shabaninejad1

  • 1Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

BMC Public Health
|March 14, 2020
PubMed
Abstract

Insights

Short-term exposure to fine particulate matter (PM2.5) is linked to an increased risk of myocardial infarction (MI). Public health strategies are crucial to mitigate air pollution and protect cardiovascular health.

Area of Science:

  • Environmental Health
  • Cardiovascular Epidemiology
  • Public Health

Background:

  • Existing literature presents conflicting findings on the association between ambient particulate matter (PM) and myocardial infarction (MI).
  • This meta-analysis focuses on short-term exposure to fine particulate matter (PM2.5).

Purpose of the Study:

  • To systematically evaluate the association between short-term exposure to PM2.5 and the risk of myocardial infarction (MI).
  • To quantify the risk of MI associated with PM2.5 exposure.

Main Methods:

  • A comprehensive literature search was performed across major databases (PubMed, Scopus, Web of Science, Embase) using keywords related to air pollution and myocardial infarction.
  • Twenty-six eligible studies were included in the meta-analysis.
  • Summary relative risk (RR) and 95% confidence intervals (95%CI) were calculated to assess the PM2.5-MI association.

Main Results:

  • A 10-μg/m³ increase in PM2.5 was significantly associated with an increased risk of MI (RR = 1.02; 95% CI 1.01-1.03; P ≤ 0.0001).
  • Moderate heterogeneity was observed across studies (I² = 69.52%).
  • Subgroup analyses indicated that time series study designs and longer study periods reduced heterogeneity.

Conclusions:

  • This meta-analysis confirms a dose-response relationship between PM2.5 exposure and MI risk.
  • Effective air pollution control strategies are essential, particularly in developing nations, to safeguard public health and prevent MI.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
284
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
123
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
468
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
164
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
792
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
284